You are here

Practice Management


Patients want healthcare cost information, but price lists alone aren’t turning them into savvy shoppers.

The healthcare delivery environment continues to evolve, requiring clinicians and practice executives to seek solutions that will lead to a pathway of success.

Concierge cardiologists report high job satisfaction along with more stable practice revenue, but experts caution specialists to learn about the differences in practice models.   

As Cardiovascular Business enters its second decade, our team has been pondering what the magazine’s pre-teen and teen years will be like. Are we looking at dignified maturity or awkward adolescence? 

Six healthcare organizations are joining forces with the goal of streamlining preapproval for patients’ medical treatments. The collaboration, they said, will give patients access to timely, affordable care while reducing administrative burdens for healthcare professionals, hospitals and insurance providers.


Recent Headlines

Avista Capital gains FDA exclusivity extension for Cardiolite Avista Capital Partners reported that the FDA has granted pediatricexclusivity for studies conducted on Cardiolite (Kit for thePreparation of Technetium Tc99m Sestamibi for Injection), which is partof its recently acquired medical imaging (MI) business fromBristol-Myers Squibb.
NovaRad secures six PACS contracts in Kansas Six healthcare facilities in Kansas are the latest to select NovaRad’sNovaPACS, bringing the company’s installations in the state to morethan 10.
Study results show Vytorin not effective for lowering family linked high cholesterol

Despite catchy TV commercials claiming Vytorin's positives of reducingcholesterol levels in patients predisposed to high cholesterol levels,a just-released study found Vytorin is no more effective in treatingpatients who were genetically predisposed to having dangerously highlevels of cholesterol than Merck's drug Zocor (Vytorin contains Zocor)because it did not slow the growth of artery blockages.

Via Pharmaceuticals begins Phase 2 of FDG-PET study Via Pharmaceuticals, a biotechnology company developing compounds for the treatment of cardiovascular disease, has enrolled the first patient in its Phase 2 clinical trial that utilizes PET with fluorodeoxyglucose tracer (FDG-PET) to measure VIA-2291's ability to reduce vascular inflammation in treated patients.
Avista concludes purchase of Bristol-Myers Squibb Medical Imaging Avista Capital Partners, a Houston-based equity firm, has completed its acquisition of Bristol-Myers Squibb (BMS) Medical Imaging.
Circulation: Out-of-hospital cardiac arrest survival rates similar after standard CPR or chest compr A simpler version of bystander-delivered cardiopulmonary resuscitation (CPR) that skips mouth-to-mouth resuscitation may be just as effective for out-of-hospital cardiac arrest victims as standard CPR, according to two studies published online on Dec. 18 in Circulation: Journal of the American Heart Association.
New study to identify high-risk individuals of MI, stroke before occurrence BG Medicine, on behalf of the High-Risk Plaque (HRP) Initiative, haslaunched the BioImage study, designed to discover new blood tests andto optimize non-invasive imaging of atherosclerosis to identify andcharacterize individuals that are at high-risk for coronary heartdisease (CHD) or stroke.
The Proof: Why Evidence-Based Medicine Improves Cardiac Care

It’s a fact: Evidence-based medicine is improving the quality and consistency of clinical care. While uniformly applying clinical data to medical practice and carefully tracking metrics requires great effort, the rewards are even greater in terms of better patient outcomes, better use of resources and balancing of costs. Two leading cardiac care facilities show how it’s done in treating acute myocardial infarction and more.

Statins Work But Pharmacoeconomic Caveats Abound

Cardiologists need to weigh the benefits of the more efficacious branded statins in comparison to the less expensive generics.

The Ticker: Quality Pays in Several Ways

Quality initiatives abound in healthcare today. One way to provide consistently better care to patients and to keep a healthy bottom line is through evidence-based medicine.